Nanophoria Bioscience
CONTACT
  • About us
    • About NanoPhoria
    • Team
    • Investors
  • Therapeutic focus
  • Our Platform
    • Drug Delivery Platform
    • Pipeline
    • Background Science
  • Clinical Programs
    • NP-MP1
  • News
    • Press releases

Author: Barnaby Pickering

NanoPhoria Announces Second Close of its Series A Round, Now with Participation from European Innovation Council Fund 

Posted on 12 January 202613 March 2026 by Barnaby Pickering
Posted in Uncategorized

NanoPhoria Named Startup of the Year by StartupItalia

Posted on 17 December 202513 March 2026 by Barnaby Pickering
Posted in Uncategorized

Recent Posts

  • NanoPhoria Announces Second Close of its Series A Round, Now with Participation from European Innovation Council Fund 
  • NanoPhoria Named Startup of the Year by StartupItalia
  • NanoPhoria Bioscience secures €83.5 Million Series A to Advance Breakthrough Heart Failure Therapy and Expand Portfolio for Novel Nano-in-Micro Delivery Platform
  • NanoPhoria Bioscience Awarded €17.5 M From European Innovation Council’s Accelerator Program
  • NanoPhoria appoints Dr Suman Shirodkar as chair and Prof. Michael Davidson as non-executive member of the Board of Directors

Recent Comments

No comments to show.

Archives

  • January 2026
  • December 2025
  • October 2025
  • February 2025
  • January 2024
  • November 2022
  • June 2022
  • May 2022

Categories

  • Uncategorized
Connect with us
Learn more about our company and the science behind our revolutionary technology platform
Get in touch
Terms of use
Privacy Policy
Cookies

© NanoPhoria S.r.l. All rights reserved.
VAT number: 12246020965